Terminated × Interventional × Small Cell Lung Carcinoma × Clear all Tamarack
Phase 2 Terminated
192 enrolled 20 charts
TRIPLEX
Phase 3 Terminated
239 enrolled
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Phase 2 Terminated
11 enrolled 10 charts
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
23 enrolled
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Phase 1 Terminated
88 enrolled
Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET
Phase 2 Terminated
20 enrolled
AM-003
Phase 1 Terminated
5 enrolled
STARBURST
Phase 2 Terminated
11 enrolled
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
Phase 3 Terminated
19 enrolled 19 charts
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Phase 2 Terminated
2 enrolled 12 charts
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Phase 1/2 Terminated
87 enrolled 29 charts
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer
Phase 1/2 Terminated
19 enrolled 10 charts
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
Phase 1/2 Terminated
54 enrolled 30 charts
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Phase 2 Terminated
205 enrolled 54 charts
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
115 enrolled
Liver Directed RT + Chemo-immunotherapy for ES-SCLC
Phase 2 Terminated
2 enrolled 1 chart
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)
Phase 1 Terminated
17 enrolled
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer
Phase 2 Terminated
6 enrolled 13 charts
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
Phase 1/2 Terminated
5 enrolled 6 charts
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
Phase 1/2 Terminated
22 enrolled 9 charts
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
Phase 2 Terminated
18 enrolled
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
26 enrolled 18 charts
SCLC
Phase 1/2 Terminated
213 enrolled 16 charts
Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer
Phase 1/2 Terminated
37 enrolled
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
Phase 1 Terminated
9 enrolled
REPLATINUM
Phase 3 Terminated
18 enrolled
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
Phase 2 Terminated
3 enrolled 13 charts
A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy
Phase 2 Terminated
45 enrolled
TORCH
Phase 1 Terminated
10 enrolled
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Phase 1 Terminated
34 enrolled
A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer
Phase 2 Terminated
24 enrolled
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Phase NA Terminated
8 enrolled 6 charts
A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC
Phase 1 Terminated
1 enrolled
KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer
Phase 2 Terminated
3 enrolled
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 14 charts
DUET-1-02
Phase 1/2 Terminated
4 enrolled 8 charts
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
Phase 2 Terminated
14 enrolled 12 charts
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
Phase 2 Terminated
9 enrolled 11 charts
A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
Phase 1 Terminated
35 enrolled
SSTR2+
Phase 1/2 Terminated
9 enrolled 4 charts
NAC-PNP
Phase NA Terminated
69 enrolled
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Phase 1 Terminated
49 enrolled
Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 Terminated
28 enrolled
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Phase 1 Terminated
10 enrolled
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)
Phase 2 Terminated
5 enrolled 5 charts
A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
Phase 1 Terminated
2 enrolled
APG-1252 in Patients With SCLC or Advanced Solid Tumors
Phase 1 Terminated
24 enrolled
MERU
Phase 3 Terminated
748 enrolled 13 charts
A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Phase 3 Terminated
185 enrolled